Risks of Recurrent Cardiovascular Events and Mortality in 1-Year Survivors of Acute Myocardial Infarction Implanted with Newer-Generation Drug-Eluting Stents
Sungmin Lim(The University of Sydney), Kiyuk Chang(St. Mary's Hospital), Ho‐Joong Youn, Ik Jun Choi(The Catholic University of Korea Incheon St. Mary's Hospital), Doo Soo Jeon(Catholic University of Korea), Kwan Yong Lee(Catholic University of Korea), Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Byung‐Hee Hwang(The Catholic University of Korea Seoul St. Mary's Hospital), Su Nam Lee, Chan Joon Kim(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Mahn‐Won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Hyeon Woo Yim(National Institute of Environmental Health Sciences), Youngkeun Ahn(Chonnam National University Hospital), Jong Min Lee(Dongguk University), Min Chul Kim(Chonnam National University), Chul Soo Park(Asan Medical Center), Myung Ho Jeong(Veterans Health Service Medical Center), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Wook Sung Chung(The Catholic University of Korea Seoul St. Mary's Hospital), Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 13
Related Papers
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion
|Circulation|2019|398
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304